Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#42 / 42 Total
HYPR - Hyperfine Inc - Stock Price Chart
TickerHYPR [NASD]
CompanyHyperfine Inc
CountryUSA
IndustryMedical Devices
Market Cap60.11MEPS (ttm)-0.62
P/E-EPS this Y13.72%
Forward P/E-EPS next Y4.47%
PEG-EPS past 5Y-
P/S5.45EPS next 5Y-
P/B0.71EPS Q/Q19.46%
Dividend-Sales Q/Q88.62%
Insider Own34.13%Inst Own11.36%
Insider Trans-0.02%Inst Trans-5.16%
Short Float2.69%EarningsMay 13/a
Analyst Recom2.33Target Price1.27
Avg Volume87.37K52W Range0.76 - 3.28
Today 03:04AM Hyperfine Inc (HYPR) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth and Challenges (GuruFocus.com)
May-13-24 08:53PM HYPR Stock Earnings: Hyperfine Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:15PM Hyperfine, Inc. (HYPR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM Hyperfine, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-10-24 09:00AM Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European Markets (Business Wire)
May-06-24 10:00AM Will Hyperfine, Inc. (HYPR) Report Negative Earnings Next Week? What You Should Know (Zacks)
Apr-29-24 04:05PM Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024 (Business Wire)
Apr-25-24 09:35AM Down -19% in 4 Weeks, Here's Why Hyperfine (HYPR) Looks Ripe for a Turnaround (Zacks)
Apr-23-24 09:00AM Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop System Images Across Multiple Care Settings and Clinical Conditions (Business Wire)
Apr-17-24 09:00AM Leading Institutions Enroll First Alzheimers Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study (Business Wire) -8.08%
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TEISSEYRE THOMASChief Operating OfficerFeb 16 '24Sale1.113,2303,58596,526Feb 16 04:06 PM
TEISSEYRE THOMASChief Operating OfficerNov 16 '23Sale1.262,6553,34599,756Nov 17 07:34 PM
TEISSEYRE THOMASChief Operating OfficerAug 16 '23Sale2.262,7856,294102,411Aug 17 04:45 PM
Siddiqui KhanCMO and Chief Strategy OfficerAug 16 '23Sale2.261,7293,90876,981Aug 17 04:44 PM
Siddiqui KhanCMO and Chief Strategy OfficerMay 16 '23Sale1.251,7352,16978,710May 16 06:15 PM
12345
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.